Navigation Links
Joint Research by IIT-K and GSVM

The Indian Institute of Technology (IIT-K) and the Ganesh Shanker Vidyarthi Memorial (GSVM) Medical College have entered into an agreement to carry out joint research // in bringing medical knowledge and technology that would be of wider interest to all sections of society.

The two institutes have signed a memorandum of understanding (MoU) in this regard on Wednesday for increased collaboration on several fronts.

The heads of the two institutions have planned to seek assistance from each other at both graduate and the postgraduate level in addition to conducting seminars, conferences and short-term courses.

The MoU has also planned to include sharing of information about the faculty, laboratories, library materials, research publications and to exchange information relating to developments in teaching and researches.

Promoting the generation of research funds through multi-dimension collaborative research grant application are also some of the terms of the agreement.

The MoU signing agreement witnessed the presence of IIT-K Director Dr Sanjay G Dhande, Dean, Research and Development, Dr SC Srivastava, Dr Pradip Sinha, Dr Rajat Moona, Dr Harish Karnik, Dr Mukesh Sharma , S Ganesh, Asima Pradhan, Ashok Kumar and visiting Fulbright scholar from University of Texas medical branch, United States, Sanjiv Sur.

Representing the GSVM were Ganesh Shankar Vidyarthi M Medical College, dean and principal Dr SS Katiyar, Dr SN Singh, Dr Asha Agarwal, Dr BD Mangal, Dr Suschil Chandra and Dr VN Tripathi on the occasion.


Page: 1

Related medicine news :

1. New Treatment For Hip Joints
2. Joint replacement surgery outcomes may be affected by obesity and diabetes
3. New combined therapy for Knee Joint pain
4. New Hereditary Bone Joint Disorder Identified
5. Ambiguous Efficacy Of Opioid Drugs In Chronic Inflammatory Joint Pain Relief
6. A Joint Venture by Golfers And Military Forces To Combat AIDS
7. Asian Nations To Take Joint Efforts Against H5N1
8. Japanese-Indonesian Joint Venture To Produce Bird Flu Vaccine For Farm Animals
9. Increase in the Demand for Artificial Joints
10. Joint Effort among Various Nations to Tackle Bird Flu
11. Expect Aching Muscles And Joints This Sports Season
Post Your Comments:

(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... Clarkston, Michigan (PRWEB) , ... June 26, 2016 ... ... respect to fertility once they have been diagnosed with endometriosis. These women need ... but they also require a comprehensive approach that can help for preservation of ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... people are unfamiliar with. The article goes on to state that individuals are now ... of these less common operations such as calf and cheek reduction. The Los Angeles ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: